Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Omalizumab”

213 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 213 results

Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT03361111
What this trial is testing

BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment

Who this might be right for
Severe Asthma
Medical University of Warsaw 16
Testing effectiveness (Phase 2)Study completedNCT03727971
What this trial is testing

Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.

Who this might be right for
AsthmaInfertility, Female
Rigshospitalet, Denmark 66
Large-scale testing (Phase 3)Study completedNCT00046748
What this trial is testing

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 484
Early research (Phase 1)Study completedNCT02266355
What this trial is testing

Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction

Who this might be right for
Colon Cancer
Yale University 9
Large-scale testing (Phase 3)Study completedNCT00109187
What this trial is testing

An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g

Who this might be right for
Asthma
Genentech, Inc.
Post-approval studies (Phase 4)Active Not RecruitingNCT06437171
What this trial is testing

FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA

Who this might be right for
Food Allergy
AAADRS Clinical Research Center 20
Post-approval studies (Phase 4)Study completedNCT02023151
What this trial is testing

Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils

Who this might be right for
Allergic Asthma
Johns Hopkins University 17
Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing

Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3
Not applicableStudy completedNCT04648930
What this trial is testing

Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

Who this might be right for
Allergic Rhinitis
Novartis Pharmaceuticals 50
Post-approval studies (Phase 4)Study completedNCT00472030
What this trial is testing

Efficacy and Safety of Omalizumab in Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
University of Iowa 2
Testing effectiveness (Phase 2)Ended earlyNCT00086606
What this trial is testing

A Safety and Efficacy Study of Xolair in Peanut Allergy

Who this might be right for
Allergy
Genentech, Inc. 150
Large-scale testing (Phase 3)UnknownNCT04944602
What this trial is testing

Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 340
Testing effectiveness (Phase 2)Looking for participantsNCT05332067
What this trial is testing

Omalizumab Before Onset of Exacerbations

Who this might be right for
Asthma in ChildrenAtopyViral Upper Respiratory Infection
Children's National Research Institute 300
Testing effectiveness (Phase 2)Study completedNCT02477332
What this trial is testing

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 382
Large-scale testing (Phase 3)Study completedNCT01333293
What this trial is testing

The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients

Who this might be right for
Mastocytosis
University of Zurich 17
Not applicableEnded earlyNCT00287378
What this trial is testing

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

Who this might be right for
AsthmaAllergy
University of North Carolina, Chapel Hill 1
Large-scale testing (Phase 3)Study completedNCT03328897
What this trial is testing

Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 418
Testing effectiveness (Phase 2)Study completedNCT01580592
What this trial is testing

Cold Urticaria Treatment With Xolair

Who this might be right for
Cold Contact Urticaria
Charite University, Berlin, Germany 31
Post-approval studies (Phase 4)Study completedNCT00117611
What this trial is testing

Xolair in Patients With Chronic Sinusitis

Who this might be right for
Sinusitis
University of Chicago 14
Load More Results